DIANA PEREZ-CHARTON: Open Payments
NPI 1962051805 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,605 in 216 payments from 30 companies in 2025. Trend: 2023 $4,784 · 2024 $3,371 · 2025 $5,605
Food & beverage: $5,428Education: $177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 42 | $1,174 |
| Regeneron Healthcare Solutions, Inc. | 14 | $507 |
| GlaxoSmithKline, LLC. | 29 | $478 |
| Actelion Pharmaceuticals US, Inc. | 6 | $402 |
| GENZYME CORPORATION | 10 | $346 |
| Inspire Medical Systems, Inc. | 9 | $323 |
| Verona Pharma, Inc. | 8 | $281 |
| United Therapeutics Corporation | 9 | $210 |
| Insmed, Inc. | 13 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $199 |
Products named: DUPIXENT, AIRSUPRA, BREZTRI, NUCALA, INSPIRE, UPTRAVI, Ohtuvayre, FASENRA.
Industry payments across FL — which companies pay providers there.
